INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology
HQ: ES
Founded: 2019
Series B
Sector: Biotechnology
Investment Raised: USD 50m €
Valuation Remains Undisclosed
Investors: Aliath Bioventures, Asabys Partners, Centre for the Development of Industrial Technology (CDTI), European Innovation Council, imec.xpand, Instituto de Credito, Merck KGaA, Darmstadt, Germany, Vsquared Ventures
Angelini Ventures invests into extended €75.8 million Series C financing round for Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized cancer vaccines
Mission Therapeutics raises £25.2 million to progress clinical candidates in the area of mitophagy
HQ: UK
Founded: 2011
Venture – Series Unknown
Sector: Biotechnology
Investment Raised: GBP 25.2M €
Valuation Remains Undisclosed
Investors: IP Group (http://www.ipgroupplc.com/) Pfizer Venture Investments (http://www.pfizer.com/partners/venture-investments) Roche Venture Fund (http://www.venturefund.roche.com) Rosetta Capital (http://www.rosettacapital.com) Sofinnova Partners (https://sofinnovapartners.com) SR One (https://www.srone.com)
Edinburgh-based Wobble Genomics raises €9.9 million to accelerate a new wave of biotechnology innovations
HQ: UK
Founded: 2021
Seed
Sector: Biotechnology
Investment Raised: EUR 9.9M €
Valuation Remains Undisclosed
Investors: Business Growth Fund (http://www.bgf.co.uk) Eos (http://eos-advisory.com/) IQ Capital (http://www.iqcapital.vc) Mercia Ventures (http://www.mercia.co.uk/ventures) Old College Capital (http://edinburgh-innovations.ed.ac.uk/venture-investment)
Phagenesis Secures $42M Investment Led by EQT Life Sciences to Revolutionize Swallowing Disorder Treatment
HQ: UK
Founded: 2007
Series D
Sector: Biotechnology
Investment Raised: USD 42M €
Valuation Remains Undisclosed
Investors: Aphelion Capital (http://www.aphelioncapital.net) British Patient Capital (http://www.britishpatientcapital.co.uk/) EQT life science (http://www.lspvc.com) Northern Gritstone (http://northern-gritstone.com/) Sectoral Asset Management
Pfizer Ventures leads £40.5m round in UK cancer drug discovery startup Curve Therapeutics
HQ: UK
Founded: 2019
Series A
Sector: Biotechnology
Investment Raised: GBP 41M €
Valuation Remains Undisclosed
Investors: Advent Life Sciences (https://adventls.com/) British Patient Capital (https://www.britishpatientcapital.co.uk/) Columbus Venture Partners (https://columbusvp.com/) Epidarex Capital (https://epidarex.com/) Pfizer Venture Investments (https://www.pfizer.com/about/partners/venture-investments)
Investors: European regional development fund (ERDF) (https://ec.europa.eu/regional_policy/funding/erdf_en) Mercia Ventures (https://www.mercia.co.uk/ventures/) Northeast Venture Fund ( NEVF ) (https://www.nedfiventure.com/)
VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases
HQ: NL
Founded: 2020
Series A
Sector: Biotechnology
Investment Raised: EUR 129M €
Valuation Remains Undisclosed
Investors: ALS Investment Fund (https://www.alsinvestmentfund.com/) BioGeneration Ventures (https://biogenerationventures.com/en/) EQT life science (https://eqtgroup.com/private-capital/life-sciences/) Forbion Capital Partners (https://forbion.com/en) Insight Partners (https://www.insightpartners.com/) MRL Ventures Fund (https://www.mrlv.com/)
